Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000548374 | SCV000657147 | likely benign | Bethlem myopathy 1A | 2024-10-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003258877 | SCV003946200 | uncertain significance | Inborn genetic diseases | 2023-06-12 | criteria provided, single submitter | clinical testing | The c.2407G>A (p.D803N) alteration is located in exon 26 (coding exon 25) of the COL6A2 gene. This alteration results from a G to A substitution at nucleotide position 2407, causing the aspartic acid (D) at amino acid position 803 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004691912 | SCV005195213 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004735628 | SCV005349902 | uncertain significance | COL6A2-related disorder | 2024-04-08 | no assertion criteria provided | clinical testing | The COL6A2 c.2407G>A variant is predicted to result in the amino acid substitution p.Asp803Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.010% of alleles in individuals of East Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |